Skip to content
WealthTicker
Back to screener
IndexIndex FundsDirectIDCWVery High
ICICI Prudential logo

ICICI Prudential Nifty Pharma Index Fund

ICICI Prudential Mutual Fund · Best Index Funds

NAV
₹20.23
-0.74% 1D
as of 05 Oct 2026

Performance

+20.05%absolute
52-week rangePrev NAV ₹20.38
Latest ₹20.23
Low ₹16.6581st percentile of its 52-week rangeHigh ₹21.06

Scorecard

Not rated
How this is computed

Each verdict is computed from this fund's own metrics against its sub-category — the number behind it is shown, not a black-box rating. Not rated — too few comparable Index funds (same plan and option) to rank against yet.

Performance—

Not enough Index Funds peers to rank yet

Risk—

Volatility 15.0% (no category average yet)

Cost—

0.5% expense (no category average yet)

ConsistencyHigh

100% of rolling 3Y windows were positive

Strengths & concerns

Generated from this fund's own numbers against its sub-category — each point names the figure behind it.

Strengths

  • Consistent — positive in 100% of rolling 3-year windows

Concerns

No significant concerns identified.

Key Metrics

0.51%
Category —
39.44
Category —
0.92
Category —

Scheme Info

Definitions
Plan
Direct · IDCW
None
Exit Load
None
0.005%
SIP Inv.
Allowed
₹1,000
₹1,000
Nifty Pharma TRI
15 Dec 2022

Period returns (<1Y, absolute — not annualized)

Definitions
-1.39%
+1.59%
+19.89%
+15.17%

Annualized returns (≥1Y — CAGR)

Definitions
+20.08%
+20.30%
—
—
+20.51%
Advanced metrics — risk and benchmark ratios

Fund vs category average (Index Funds)

PeriodFundCategory avg.Diff
1M abs-1.39%——
3M abs+1.59%——
6M abs+19.89%——
1Y CAGR+20.08%——
3Y CAGR+20.30%——
5Y CAGR———

Category average across peers in Index Funds, same plan and option, excluding this fund. Under-1-year figures are absolute; 1Y and beyond are annualised (CAGR).

Not sure what a figure means? The glossary explains every metric, and the methodology shows the formulas.

Backtest this fund

What a SIP or one-time investment would have grown to over this fund’s real NAV history.

Period
Invested
₹3.60L
Current value
₹4.41L
Absolute
+22.54%
XIRR
+14.41%
Value vs. invested
ValueInvested

36 monthly installments of ₹10,000 into ICICI Prudential Nifty Pharma Index Fund, valued at the latest NAV. XIRR annualizes for each installment’s timing.

Calendar-year returns

What the fund actually returned in each year, not the smoothed average.

YearFundNifty 500 TRIDiff
2026part+15.17%-7.18%+22.35%
2025-2.59%+7.94%-10.53%
2024+38.82%+16.43%+22.39%
2023+32.86%+27.43%+5.43%
2022part-1.68%——

January–December, from this fund's NAV history. Absolute return, not annualised. “part” marks a year the fund didn't run end to end — its first year, the current year so far, or one it stopped reporting in; those years show no benchmark comparison.

History points
936
Expense ratio
0.51%
AUM
₹121.63Cr
Portfolio turnover
30%
Exit load
Nil
Portfolio, AUM & scheme details shown from another plan of this scheme (same underlying portfolio).
P/E ratio
39.4
P/B ratio
7.4
Avg market cap
₹1,81,175Cr
P/E & P/B are portfolio-weighted harmonic means across 18 of 20 equity holdings (97% of the portfolio); loss-making companies are excluded.

Taxation

Taxed as equity

This is an equity-oriented fund (≥65% in Indian equities), so gains get the concessional capital-gains rates below — they do not add to your income-tax slab.

Short-term (STCG)
20%
Held under 1 year

Flat, on the whole gain

Long-term (LTCG)
12.5%
Held 1 year or more

On gains above ₹1.25 L per financial year

Applies to capital gains on redemption. Excludes IDCW/dividend tax, STT, surcharge and cess, and pre-2018 equity grandfathering. For research only — consult a tax advisor before filing.

Asset allocation

As on 31 Aug 2026 · AMC disclosure
  • Equity99.93%
  • Cash & Equivalents0.07%

Fund size over time

Quarterly average AUM · AMFI
₹121.63Cr
April - June 2026
+26%
since January - March 2026
+₹14.27Cr
est. net flow, last quarter

At or near its largest, ₹121.63Cr in April - June 2026. Size matters most where the mandate is narrow — a large small-cap or a very large flexi-cap book is harder to move without moving the price.

Net flow is an estimate: AMFI publishes a quarterly average AUM, not a closing balance, and it covers every plan and option of this scheme together, so it is a read on direction and rough size rather than a cash-flow statement.

ICICI Prudential Mutual Fund logo

AMC Profile

ICICI Prudential Mutual Fund is a joint venture between ICICI Bank and Prudential plc of the UK, in business since 1993. It is among India's largest houses by assets and runs one of the industry's widest scheme line-ups across equity, debt and hybrid.

Launched
11 Oct 1993
Total AUM
₹11,14,544Cr+1.0% QoQ
Avg AUM · April - June 2026

Fund Managers

NPNishit PatelStart date not disclosed
Role

Fund Manager – Passive Funds

Education

Chartered Analyst (CFA) (Level I), Chartered and B.Com

Experience

Mr. Nishit joined ICICI Prudential Asset Management Company Limited in November 2017. He has over 7 years of experience. Past Experience: ~ ICICI Prudential Asset Management Company Limited – ETF Business - November 2017 – January 2020. •

Funds managed (58)
All schemes Nishit Patel runs →
ASAshwini ShindeStart date not disclosed
Role

Manager - Dealer Support

Total experience

Over 6 years

Education

Bachelor of Commerce (B.Com), Master of Commerce (M.Com) from Mumbai University and Inter CA

Experience

During November 2024, Ms. Ashwini was appointed as fund manager for certain passive schemes. Prior to this she was working as the Deputy Manager Dealer Support in the Investment Department of ICICI Prudential Asset Management Company Limited w.e.f. August 1, 2024. Past Experience: ~ ICICI Prudential Asset Management Company Limited - Treasury Mutual Fund Operations - March 14, 2016 to January 30, 2020 ~ ICICI Prudential Asset Management Company Limited - Treasury Mutual ICICI Prudential Nifty IT ETF Fund Operations - August 3, 2021 to July 31, 2024.

Funds managed (57)
All schemes Ashwini Shinde runs →
VAVenus AhujaStart date not disclosed
Role

Dealer – ETF

Total experience

Over 3 years

Education

Chartered Accountant and B.Com

Experience

Ahuja has appointed as the Fund effect from dealer in the Company Asset Company – Investment August 6

Funds managed (34)
All schemes Venus Ahuja runs →

Fund manager, benchmark and dealing terms from this scheme's SEBI-filed Scheme Information Document on AMFI. Each manager's qualifications and role are reconciled across every filing this fund house makes for them, including its Statement of Additional Information. Total AUM via AMFI.

Returns and risk are computed from NAV history and may differ slightly from other portals due to methodology (rolling vs point-to-point, dividend treatment). For research only — not investment advice.

About Index funds & ETFs

Index funds and ETFs must keep at least 95% in the securities of the index they track, rather than trying to beat it. They charge far lower fees than active funds, and their return is the index's return minus that small cost and any tracking difference.

Frequently asked questions

What is the NAV of ICICI Prudential Nifty Pharma Index Fund?

As of 05 Oct 2026, the NAV of ICICI Prudential Nifty Pharma Index Fund is ₹20.23 per unit. NAV (net asset value) is the fund's per-unit price, published once each business day.

What returns has ICICI Prudential Nifty Pharma Index Fund delivered?

ICICI Prudential Nifty Pharma Index Fund has returned +20.08% over 1 year, +20.30% per year over 3 years and +20.51% per year since inception. Figures beyond one year are annualised (CAGR) and are computed from AMFI NAV history, so they may differ slightly from other portals.

What is the expense ratio of ICICI Prudential Nifty Pharma Index Fund?

ICICI Prudential Nifty Pharma Index Fund charges an expense ratio of 0.51% per year. This annual fee is already deducted from the NAV, so the returns you see are net of it.

What are the top holdings of ICICI Prudential Nifty Pharma Index Fund?

ICICI Prudential Nifty Pharma Index Fund's largest holdings are Sun Pharmaceutical Industries Ltd. (20.8%), Divi's Laboratories Ltd. (11.9%), Cipla Ltd. (7.8%), Laurus Labs Ltd. (7.4%) and Torrent Pharmaceuticals Ltd. (7.3%). Holdings are disclosed monthly and change over time.

How risky is ICICI Prudential Nifty Pharma Index Fund?

ICICI Prudential Nifty Pharma Index Fund is rated very high on SEBI's risk-o-meter, its trailing-3Y volatility (annualised) is 15.0% and its worst peak-to-trough fall in our sample was -16.6%. Higher volatility means the NAV swings more; the drawdown shows how far it has fallen from a peak historically.

What does the Sharpe ratio of 0.92 mean?

The Sharpe ratio is return earned per unit of total risk, above a 6.5% risk-free rate. ICICI Prudential Nifty Pharma Index Fund's 0.92 means it has rewarded its volatility with excess return. Higher is better.

What is the benchmark of ICICI Prudential Nifty Pharma Index Fund?

ICICI Prudential Nifty Pharma Index Fund is benchmarked against the Nifty Pharma TRI. Its alpha and beta on this page are measured against that index.

Who manages ICICI Prudential Nifty Pharma Index Fund?

ICICI Prudential Nifty Pharma Index Fund is managed by Nishit Patel, Ashwini Shinde and Venus Ahuja at ICICI Prudential.

How is ICICI Prudential Nifty Pharma Index Fund taxed?

ICICI Prudential Nifty Pharma Index Fund is an equity-oriented fund, so its capital gains get concessional rates: short-term gains (units held under 1 year) are taxed at 20%, and long-term gains (held 1 year or more) at 12.5% above a ₹1.25 lakh per-year exemption. These rates apply on redemption and don't add to your income-tax slab.